A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Parkinsonism & Related Disorders

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2011.07.007PMID 21824799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The clinically important difference on the unified Parkinson's disease rating scale.

  2010cited by this paper
• Hormonal Replacement Therapy in Women With Parkinson Disease and Levodopa-Induced Dyskinesia: A Crossover Trial

  2007cited by this paper
• Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.

  2006cited by this paper
• Postmenopausal estrogen use affects risk for Parkinson disease.

  2004cited by this paper
• Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy.

  2001cited by this paper
• Estrogen use among nursing home residents with a diagnosis of Parkinson's disease

  2000cited by this paper
• Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations

  2000cited by this paper
• Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients

  1999cited by this paper
• Effects of female sex steroids on Parkinson's disease in postmenopausal women.

  1999cited by this paper
• Effect of Chronic Estradiol and Progesterone Treatments of Ovariectomized Rats on Brain Dopamine Uptake Sites

  1993cited by this paper

• Unveiling the Role of Sex Hormones and Reproductive Life Factors in Parkinson's Disease.

  2026cites this paper
• Differentiating between the impact of sex and gender in Parkinson’s disease: utilising these to advance current understanding and care practices

  2026cites this paper
• Dual disease co-expression analysis reveals potential roles of estrogen-related genes in postmenopausal osteoporosis and Parkinson’s disease

  2025cites this paper
• Menopause triggers microglia-associated neuroinflammation in Parkinson's disease.

  2025cites this paper
• Ovarian Aging: The Silent Catalyst of Age-Related Disorders in Female Body

  2025cites this paper
• Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases.

  2025cites this paper
• The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease

  2024cites this paper
• Reproductive life factors and estro-progestin exposure in women with early-onset Parkinson's disease compared to late-onset disease and controls: A retrospective cohort study.

  2024cites this paper
• Sex-focused analyses of M83 A53T hemizygous mouse model with recombinant human alpha-synuclein preformed fibril injection identifies female resilience to disease progression: A combined magnetic resonance imaging and behavioural study

  2024cites this paper
• Medical, surgical, and physical treatments for Parkinson's disease.

  2024cites this paper
• Sex and Gender Differences in Parkinson's Disease.

  2023cites this paper
• Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease

  2023cites this paper
• The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape.

  2023cites this paper
• Hormone therapy for sexual function in perimenopausal and postmenopausal women.

  2023cites this paper
• Sex differences in alpha-synucleinopathies: a systematic review

  2023cites this paper
• Potential Regulation of miRNA-29 and miRNA-9 by Estrogens in Neurodegenerative Disorders: An Insightful Perspective

  2023cites this paper
• Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

  2022cites this paper
• Sex differences in Parkinson's Disease: An emerging health question

  2022cites this paper
• Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.

  2022cites this paper
• Editorial: Inclusion, equity, diversity and social justice in movement disorders research.

  2021cites this paper
• Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study

  2021cites this paper
• Estrogen Signaling Based Current and Potential Therapies Against Obesity and Related Diseases

  2021cites this paper
• Effects of the Menstrual Cycle on Neurological Disorders

  2021cites this paper
• A Report of Tamoxifen and Parkinson's Disease in a US Population and a Review of the Literature

  2021cites this paper
• Metabolic profile in plasma and CSF of levodopa-induced dyskinesia of Parkinson's disease

  2020cites this paper
• Gender Differences and Quality of Life in Parkinson’s Disease

  2020cites this paper
• Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease

  2019influential citation
• Does hormone replacement therapy benefit post-menopausal women? – a scoping review

  2019cites this paper
• An overview of the neuroendocrine system in Parkinson’s disease: what is the impact on diagnosis and treatment?

  2019cites this paper
• Movement Disorders in Women

  2017cites this paper
• Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson’s Disease

  2017cites this paper
• The relevance of gender in Parkinson’s disease: a review

  2017cites this paper
• Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease

  2017cites this paper
• Estrogen and Alzheimer's disease: Still an attractive topic despite disappointment from early clinical results

  2017cites this paper
• Differences Between Intact and Ovariectomized Hemiparkinsonian Rats in Response to L-DOPA, Melatonin, and L-DOPA/Melatonin Coadministration on Motor Behavior and Cytological Alterations

  2017cites this paper
• 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy

  2016cites this paper
• REcomendaciones 2016 de la IMS sobre salud de la mujer de edad mediana y terapia hormonal de la menopausia

  2016cites this paper
• Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease

  2016cites this paper
• Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.

  2016cites this paper
• Inhibition of Rho‐kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide‐mediated Parkinson's model

  2016cites this paper
• Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease

  2016influential citation
• Polymersome Mediated Delivery of Mitochondrial therapeutics to parkin Mutant Fibroblasts

  2015cites this paper
• Sex differences in Parkinson's disease and other movement disorders.

  2014cites this paper
• Perimenstrual Fluctuations in Two Siblings With Early‐Onset Parkinson's Disease

  2014cites this paper
• Hormone replacement therapy and Parkinson’s disease risk in women: a meta-analysis of 14 observational studies

  2014influential citation
• No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial

  2014cites this paper
• Female reproductive factors, menopausal hormone use, and Parkinson's disease

  2014cites this paper
• Hormone therapy for sexual function in perimenopausal and postmenopausal women.

  2013cites this paper
• Reproductive factors and clinical features of Parkinson's disease.

  2013cites this paper
• Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression.

  2013cites this paper
• Perimenopause Amelioration of a TCM Recipe Composed of Radix Astragali, Radix Angelicae Sinensis, and Folium Epimedii: An In Vivo Study on Natural Aging Rat Model

  2013cites this paper
• Estrogen synthesis and signaling pathways during aging: from periphery to brain.

  2013cites this paper
• Neuroprotective Effect of Genistein : Studies in Rat Models of Parkinson’s and Alzheimer’s Disease

  2012cites this paper
• Hormone Replacement Therapy and Risk for Neurodegenerative Diseases

  2012cites this paper